Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

Press releases published on October 6, 2026

Aventis Energy Announces Fall Surface Exploration Program at the Corvo Uranium Project
SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia
First Atlantic Nickel & Cobalt Raises Total of $13.4 Million with Additional $3.49 Million No-Warrant, Non-Brokered Private Placement at $0.83 per Share, a Premium to Market, to Accelerate Exploration at Pipestone XL Nickel-Cobalt Alloy Project
Zenas BioPharma to Host Virtual R&D Event
Shopify to Announce Third-Quarter 2026 Financial Results
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
Newcore Gold Drilling Intersects 1.16 g/t Gold over 41.0 Metres, Including 2.54 g/t Gold over 13.0 Metres, at the Enchi Gold Project, Ghana
HI-VIEW RESOURCES COMPLETES 2026 EXPLORATION FIELD PROGRAM IN THE TOODOGGONE MINING DISTRICT, BRITISH COLUMBIA
RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01
Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
Production update and FTSE 250 Index inclusion
Framleiðsluuppfærsla og innganga í FTSE 250 vísitöluna

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa Daily Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.